USC Norris Comprehensive Cancer Center
An NCI-designated Comprehensive Cancer Center
Leadership
Senior Leadership
Caryn Lerman, PhD
Director, USC Norris Comprehensive Cancer Center
Lourdes Baezconde-Garbanati, MPH, PhD
Associate Director,
Community Outreach & Engagement
Peggy Farnham, PhD
Associate Director, Basic Research
Amir Goldkorn, MD
Associate Director, Translational Research
Heinz-Josef Lenz, MD
Associate Director, Clinical Research
Mariana Stern, PhD
Associate Director, Population Science
Alan S. Wayne, MD
Associate Director, Pediatric Oncology
David Conti, PhD
Associate Director, Data Science
Yves DeClerck, MD
Associate Director, Cancer Research Training and Education
Amy S. Lee, PhD
Associate Director, Shared Resources
Anthony B. El-Khoueiry, MD
Director, Clinical Investigations Support Office
Christopher Loertscher, MA
Associate Director for Administration & Chief Administrative Officer
Steven Grossman, MD, PhD
Cancer Physician in Chief
Program Leaders
Genomic and Epigenomic Regulation
The program is led by Michael Stallcup, PhD, who has made breakthrough discoveries on chromatin structure and function, and Yali Dou, PhD, known for translation of epigenetic discoveries into novel inhibitors.
Michael Stallcup, PhD
Co-Leader
Yali Dou, PhD
Co-Leader
Tumor Microenvironment
The program co-leaders, W. Martin Kast, PhD, and Rongfu Wang, PhD, have complementary recognized expertise in cancer virology & cancer immunology and in immunotherapy, innate immune signaling & epigenetic programming, respectively.
W. Martin Kast, PhD
Co-Leader
Rongfu Wang, PhD
Co-Leader
Translational and Clinical Sciences
John Carpten, PhD
Co-Leader
Heinz-Josef Lenz, MD
Co-Leader
Parkash Gill, MD
Co-Leader
Cancer Epidemiology
Wendy Setiawan, PhD
Co-Leader
Christopher A. Haiman, ScD
Co-Leader
Cancer Control Research
Myles Cockburn, PhD
Co-Leader
Jennifer Unger, PhD
Co-Leader